Auro Revenue and Competitors
Estimated Revenue & Valuation
- Auro's estimated annual revenue is currently $4.6M per year.
- Auro's estimated revenue per employee is $231,000
Employee Data
- Auro has 20 Employees.
- Auro grew their employee count by 0% last year.
Auro's People
Name | Title | Email/Phone |
---|
Auro Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7858.2M | 17009 | 0% | N/A | N/A |
#2 | $8.2M | 31 | -24% | N/A | N/A |
#3 | $5.3M | 23 | 0% | N/A | N/A |
#4 | $11.1M | 42 | 2% | N/A | N/A |
#5 | $6.7M | 29 | 0% | N/A | N/A |
#6 | $63.2M | 174 | 9% | N/A | N/A |
#7 | $67.5M | 186 | 58% | N/A | N/A |
#8 | $17.8M | 60 | 3% | N/A | N/A |
#9 | $17.2M | 58 | -8% | N/A | N/A |
#10 | $12.4M | 47 | 7% | N/A | N/A |
What Is Auro?
Developing L4 autonomous driving technologies
keywords:N/AN/A
Total Funding
20
Number of Employees
$4.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Auro News
2022-04-20 - Diclofenac Sodium Market Size, Scope And Forecast | Auro ...
Auro Laboratories Limited, Henan Dongtai Pharmaceutical Co., Bayer AG, Pfizer Inc., Hunan Warrant Pharmaceutical Co., Novartis AG,...
2022-04-19 - Woman got ghosted after saying she wanted to name her baby 'Megatron'
auro ( auro) 1650648255. Emily here dodged a bullet cuz thatu2019s a hilarious response.https://twitter.com/emilykaitlinnn/status/...
2022-04-17 - Diclofenac Sodium Market Size And Forecast | Auro ...
Auro Laboratories Limited, Henan Dongtai Pharmaceutical Co., Bayer AG, Pfizer Inc., Hunan Warrant Pharmaceutical Co., Novartis AG,...
2022-04-17 - Diclofenac Sodium Market Size And Forecast | Auro ...
Auro Laboratories Limited, Henan Dongtai Pharmaceutical Co., Bayer AG, Pfizer Inc., Hunan Warrant Pharmaceutical Co., Novartis AG,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 20 | -49% | $70M |
#2 | $4.6M | 20 | 0% | N/A |
#3 | $2.1M | 21 | -5% | N/A |
#4 | $2.1M | 21 | -16% | N/A |
#5 | $2.1M | 21 | -16% | N/A |